Article citationsMore>>

(1992) FDA’s Policy Statement for the Development of New Stereoisomeric Drugs. Chirality, 4, 338-340.
https://doi.org/10.1002/chir.530040513

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top